AHCO AdaptHealth Corp.
Services-Home Health Care Services · Nasdaq · SEC CIK 1725255 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY6.3%
TTM net income YoY-594.6%
TTM EPS YoY-632.1%
Revenue 3-yr CAGR0.3%
Net income 3-yr CAGR—
Margins
Gross margin15.9%
Operating margin-11.5%
Net margin-12.9%
FCF margin2.6%
EBITDA margin2.2%
Returns
ROE-28.6%
ROA-9.5%
ROIC (approx.)-8.9%
Asset turnover0.73x
Leverage & solvency
Liabilities / assets70.6%
Debt / equity1.54x
Current ratio1.13x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-1.42x
Accruals ratio-23.0%
Payout ratio—
Capex / revenue15.8%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $3.24B | $3.26B | $3.20B | $2.97B | $2.45B |
| Cost of revenue | $2.64B | $2.58B | $2.58B | $2.39B | $2.01B |
| Gross profit | $609.20M | $681.09M | $624.07M | $580.12M | $445.61M |
| SG&A expense | $382.29M | $359.24M | $334.59M | $324.81M | $167.50M |
| Operating income | $90.87M | $263.73M | -$598.40M | $190.41M | $225.60M |
| Interest expense | $103.60M | $124.70M | $131.00M | $112.40M | $95.19M |
| Pretax income | -$15.15M | $136.02M | -$723.78M | $97.90M | $190.96M |
| Income tax | $50.88M | $41.24M | -$49.00M | $24.77M | $32.81M |
| Net income | -$70.79M | $90.42M | -$678.89M | $69.32M | $156.18M |
| EBITDA | $472.80M | $629.07M | -$215.62M | $541.59M | $483.66M |
| EPS (basic) | -0.52 | 0.62 | -5.06 | 0.47 | 1.12 |
| EPS (diluted) | -0.52 | 0.61 | -5.31 | 0.33 | 0.67 |
| Weighted avg. shares (diluted) | 135.15M | 135.53M | 134.42M | 138.99M | 133.03M |
| Balance sheet | |||||
| Cash & equivalents | $106.14M | $109.75M | $77.13M | $46.27M | $149.63M |
| Receivables | $370.90M | $408.02M | $388.91M | $359.15M | $359.90M |
| Inventory | $114.89M | $139.84M | $113.64M | $127.75M | $123.09M |
| Current assets | $728.90M | $755.79M | $649.02M | $585.31M | $670.06M |
| PP&E, net | $503.19M | $474.56M | $495.10M | $487.08M | $398.58M |
| Goodwill | $2.46B | $2.68B | $2.72B | $3.55B | $3.51B |
| Intangibles | $35.77M | $105.55M | $130.16M | $162.77M | $202.23M |
| Total assets | $4.32B | $4.49B | $4.51B | $5.22B | $5.25B |
| Current liabilities | $712.39M | $566.99M | $537.00M | $456.21M | $499.81M |
| Short-term debt | $20.31M | $16.25M | $53.37M | $35.00M | $20.00M |
| Long-term debt | $1.72B | $1.96B | $2.09B | $2.15B | $2.18B |
| Total debt | $1.74B | $1.98B | $2.15B | $2.19B | $2.20B |
| Total liabilities | $2.79B | $2.91B | $3.04B | $3.06B | $3.18B |
| Shareholders' equity | $1.52B | $1.57B | $1.46B | $2.15B | $2.06B |
| Net debt | $1.63B | $1.87B | $2.07B | $2.14B | $2.05B |
| Shares outstanding | 135.45M | 134.60M | 132.63M | 134.44M | 133.84M |
| Cash flow statement | |||||
| Operating cash flow | $601.77M | $541.84M | $480.67M | $373.87M | $275.68M |
| Capital expenditure | $382.39M | $306.06M | $337.46M | $391.42M | $203.31M |
| Free cash flow | $219.38M | $235.78M | $143.20M | -$17.56M | $72.37M |
| Investing cash flow | -$303.19M | -$310.27M | -$357.28M | -$411.17M | -$1.82B |
| Financing cash flow | -$302.19M | -$198.95M | -$92.53M | -$66.05M | $1.60B |
| Depreciation & amortization | $381.93M | $365.33M | $382.78M | $351.18M | $258.05M |
| Stock-based compensation | $21.88M | $14.88M | $22.47M | $22.40M | $25.32M |
| Share buybacks | $0 | $0 | $29.27M | $13.99M | $0 |
Free plan shows the latest 5 periods; Pro shows all 8 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.